Morgan Stanley keeps HKD 207.40 target for WuXi AppTec stock

Morgan Stanley kept its HKD 207.40 target for WuXi AppTec stock on October 14, 2026, while retaining its Overweight rating, according to Futu. The target was 2.67 percent above the HKEX price of HKD 202.00 at the October 14, 2026 market snapshot. At Lang & Schwarz, WuXi AppTec was trading at EUR 23.09 on October 14, 2026 at 3:31 p.m. CEST.

Revenue estimates point higher

Analysts expect third-quarter revenue of HKD 18.10 billion, up 37.55 percent from HKD 13.16 billion in the prior-year quarter, according to Finanzen.ch on October 12, 2026. The same estimate set puts earnings per share at HKD 2.97, compared with HKD 1.35 in the prior-year quarter.

The revenue estimate gives the stock a measurable earnings-calendar marker. WuXi AppTec is expected to report figures for the quarter ended September 30, 2026, on October 27, 2026, according to Finanzen.ch.

Stock remains below yearly high

The HKEX quote stood at HKD 202.00 on October 14, 2026 at 4:08 p.m. HKT, down 2.60 percent from the October 13, 2026 close of HKD 207.40. Its 52-week range was HKD 96.70 to HKD 219.20, placing the price 7.85 percent below the high. Trading volume reached 5,470,984 shares against an average of 5,669,116.

The euro quote gives German investors a separate currency reference. The Lang & Schwarz price of EUR 23.09 was 2.60 percent below the October 13, 2026 HKEX close on October 14, 2026 at 3:31 p.m. CEST.

Valuation and peers

WuXi AppTec had a market capitalization of HKD 585.1 billion and a price-to-earnings ratio of 20.72 on October 14, 2026. Its trailing dividend yield was 0.01 percent. The company describes itself as a pharmaceutical contract research, development and manufacturing organization serving partners across more than 30 countries, according to WuXi AppTec.

Comparison with peers

WuXi AppTec (HKEX, HKD): minus 2.60 percent, P/E 20.72, market capitalization HKD 585.1 billion
Pharmaron Beijing (HKEX, HKD): minus 2.31 percent, P/E 41.24, market capitalization HKD 76.0 billion
Hangzhou Tigermed Consulting (HKEX, HKD): minus 1.89 percent, P/E 663.38, market capitalization HKD 50.4 billion

Price and reporting date

WuXi AppTec was trading at EUR 23.09 at Lang & Schwarz on October 14, 2026 at 3:31 p.m. CEST, down 2.60 percent on HKEX versus the October 13, 2026 close. The further course of trading is shown by the continuously updated real-time quote of WuXi AppTec stock.

Market context: Current market reports.

More news and analyses on WuXi AppTec stock